Efficient mobilization of PBSC with vinorelbine/G-CSF in patients with malignant lymphoma
- 26 January 2009
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 44 (2), 75-79
- https://doi.org/10.1038/bmt.2008.434
Abstract
High-dose chemotherapy (HDT) and hematopoietic SCT are effective in patients with relapsing or refractory malignant lymphoma. Collection of sufficient numbers of stem cells is a prerequisite for such a therapy. In a pilot trial, we evaluated the feasibility of stem cell mobilization with vinorelbine/G-CSF in patients with lymphoma, a regimen allowing precise timing and harvesting of sufficient stem cells in myeloma patients. Forty-five patients with lymphoma received vinorelbine 35 mg/m2 i.v. on day 1 and G-CSF 10 μg/kg/day s.c., divided in two daily doses from day 4 until collection. Stem cell collection was successfully performed in 43 patients (96%) with a median of 3.6 × 106 CD34+ cells/kg (range: 1.4–16) in the collected product. In 28 patients (62%), the first stem cell apheresis was performed on day 8, and for 28 patients a sufficient stem cell yield was reached with one apheresis only. All 43 patients underwent high-dose chemotherapy with BEAM and auto-SCT with hematological recovery on time and without unexpected toxicity. In conclusion, vinorelbine/G-CSF allows accurate timing and safe harvesting of sufficient stem cells in patients with malignant lymphoma.Keywords
This publication has 11 references indexed in Scilit:
- Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin diseaseBritish Journal of Haematology, 2006
- Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell SupportNew England Journal of Medicine, 2004
- Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effectiveBone Marrow Transplantation, 2003
- Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphomaBone Marrow Transplantation, 2001
- Randomized Cross-Over Trial of Progenitor-Cell Mobilization: High-Dose Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor (G-CSF) Versus Granulocyte-Macrophage Colony-Stimulating Factor Plus G-CSFJournal of Clinical Oncology, 2000
- Vinorelbine in the treatment of lymphomaHematological Oncology, 1998
- Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma.Journal of Clinical Oncology, 1998
- Vinorelbine: A New Promising Drug in Hodgkin's DiseaseLeukemia & Lymphoma, 1996
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995
- Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphomaBlood, 1994